与苏尼蒂尼布治疗相关的渐进性破坏性甲状腺功能低下症:三年病例分析
1Collegium Medicum, Jan Dlugosz University in Częstochowa, Waszyngtona 4/8 Street, 42-200 Częstochowa, Poland.
Journal of clinical medicine
|January 28, 2026
概括
治疗细胞癌的苏尼提尼布治疗可能会导致逐渐破坏性的甲状腺功能低下症. 定期的甲状腺监测和levothyroxine治疗对于控制这种副作用和继续癌症治疗至关重要.
科学领域:
- 内分泌学 在内分泌学.
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 苏尼蒂尼布是一种氨酸激酶抑制剂 (TKI),用于细胞癌.
- 甲状腺功能障碍是TKI治疗的已知副作用,但尚未完全理解.
- 由TKI引起的甲状腺功能障碍的机制和临床进展需要进一步阐明.
研究的目的:
- 分析sunitinib治疗对甲状腺功能的纵向影响,对患有转移性清细胞癌的患者进行分析.
- 为了将甲状腺功能测试结果,临床症状和超声检测结果与sunitinib治疗周期和剂量相关联.
- 评估TKI诱导的甲状腺功能低下症的内分泌管理策略.
主要方法:
- 一个患有转移性清细胞细胞癌的单个患者的纵向病例分析.
- 监测甲状腺功能测试 (TSH,自由甲状腺激素),临床症状和甲状腺超声波.
- 发现与循环性苏尼提尼布治疗 (4周,2周休息) 和剂量调整的相关性.
主要成果:
- 苏尼蒂尼布治疗导致TSH显著增加,进展为持续性甲状腺功能低下症,需要甲状腺素替代剂.
- 甲状腺超声波显示,在三年内,甲状腺膜逐渐破坏,腺体体积显著减少.
- 用levothyroxine进行内分泌管理允许生物化学性甲状腺功能减退和不间断的瘤治疗.
结论:
- 苏尼蒂尼布治疗可以诱导逐渐破坏性的甲状腺功能低下症.
- 在sunitinib治疗期间,定期监测甲状腺功能是必不可少的.
- 及时的levothyroxine治疗对于治疗甲状腺功能低下症至关重要,使癌症治疗和症状控制得以继续.
相关概念视频
01:12Non-destructive Tests for Concrete Strength
525
The rebound hammer test, also known as the Schmidt hammer test, is a non-destructive technique for evaluating the hardness of concrete and, indirectly, the strength of concrete. It operates on the principle that the rebound of a spring-driven mass from a concrete surface correlates to the surface's hardness. The device comprises a mass within a tubular housing, a spring mechanism, and a plunger that strikes the concrete. Upon release, the energy imparted to the mass by the spring causes it...
525
02:07Tumor Progression
7.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.4K
00:59Gene Therapy
27.6K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.6K
03:03mTOR Signaling and Cancer Progression
4.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.7K
01:26Group Therapy
423
Group therapy is a sociocultural approach to psychological treatment, where individuals with shared psychological challenges come together under the guidance of a mental health professional. This therapeutic modality offers unique opportunities for individuals to connect, share, and grow within the context of a supportive group. By fostering mutual understanding and collaboration, group therapy can address a range of psychological concerns effectively, often complementing or surpassing the...
423
02:49Cancer Therapies
10.1K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.1K